|30 Hudson Street , Jersey City, NJ 07302|
|Fund Manager||Team Managed|
The Fund seeks long-term growth of capital.The Fund is a "fund of funds" that seeks to achieve its investment objective by investing primarily in mutual funds and exchange-traded funds managed by New York Life Investment Management LLC (New York Life Investments) or its affiliates (the "Underlying Funds"). The Underlying Funds are described and offered for direct investment in separate prospectuses. The Fund is designed for investors with a particular risk profile as represented by the asset class allocations described below,and invests in a distinct mix of Underlying Funds. The Fund seeks to achieve its investment objective by normally investing substantially all of its assets in Underlying Equity Funds (normally within a range of 90% to 100%).The Fund may invest approximately 25% (within a range of 15% to 35%) of its assets in Underlying International Equity Funds. The Fund may invest up to 10% of its assets in Underlying Fixed-Income Funds. New York Life Investments may change the asset class allocations, the Underlying Funds in which the Fund invests,or the target weighting without approval from shareholders. With respect to investments in Underlying Funds that invest significantly in both U.S. and non-U.S. equity securities, New York Life Investments will generally allocate such investments equally between Underlying U.S. Equity Funds and International Equity Funds.New York Life Investments will determine each Underlying Funds asset class, and for Underlying Funds that may potentially fall into multiple asset classes, New York Life Investments will classify them based on certain factors, including, but not limited to, the Underlying Fund's investment strategy and portfolio characteristics. The Underlying Funds may engage in strategies involving non-traditional asset classes (e.g., master limited partnerships), non-traditional investment strategies (e.g., non-correlated returns or short sales) or illiquid assets.New York Life Investments uses a two-step asset allocation process to create the Fund's portfolio.The first step includes a strategic review of the target allocations to the equity and fixed-income asset classes and a determination of any tactical allocation adjustments to establish the portion of the Fund's investable portfolio (meaning the Fund's assets available for investment, other than working cash balances) to be invested in each asset class.
|Asset Type||% Of Allocation|
|Total Net Assets||16.31 M|
|Criteria||3 Years||5 Years||10 Years|
|Minimum Initial IRA||$0|
|Timeframe||Average Annual Current Performance Monthly As Of 08/31/2021||Average Annual Current Performance Quarterly As Of 06/30/2021||Avg Annual Current Performance Monthly As Of 08/31/2021||Avg Annual Current Performance Quarterly As Of 06/30/2021|
|Life Of Fund||
|Symbol||Company Name||% Of Assets|
|MLAAX||MAINSTAY LARGE CAP GROWTH||9.90%|
|MSOAX||MAINSTAY COMMON STOCK FD||8.56%|
|IQSU||IQ CANDRIAM ESG US EQUITY ETF||8.17%|
|MAPAX||MAINSTAY MAP FUND||7.18%|
|CLRG||IQ CHAIKIN US LARGE CAP ETF||6.52%|
|EPLPX||MAINSTAY EPOCH US EQUITY YLD||5.99%|
|MOPAX||~MAINSTAY SMALL CAP OPP FUND||5.22%|
|MCYCX||MAINSTAY CANDRIAM EM MKT EQ F||4.86%|
|CSML||IQ CHAIKIN US SMALL CAP ETF||4.69%|
|IQIN||IQ 500 INTERNATIONAL ETF||4.10%|
Join the Action Alerts PLUS Community today!
From inflation worries to high natural gas prices and the chip shortage, Jim Cramer spotlights the issues weighing on the markets.
Micron topped analysts' fourth quarter expectations but provided tepid outlook for the first quarter.
Wolfe Research upgraded Chewy to outperform, saying a drop in net new customer additions should reverse in fiscal 2022.
Ahead of third-quarter earnings season, James 'Rev Shark' Deporre has some thoughts on what investors should be thinking about.
Gogo, Huntsman, Thor Industries, United Natural Foods and Sonoma Pharmaceuticals are five top stock gainers for Tuesday.